Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
As at 2022-12-31 |
As at 2021-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification |
Nyxoah SA
|
— | — |
| Domicile of entity |
|
— | — |
| Legal form of entity |
société cotée
|
— | — |
| Country of incorporation |
Belgique
|
— | — |
| Principal place of business |
12 rue
|
— | — |
| Description of nature of entity's operations and principal activities |
La Société opère dans le secteur des technologies médicales. Elle se concentre sur le développement
|
— | — |
| Name of parent entity |
Nyxoah SA
|
— | — |
| Name of ultimate parent of group |
Nyxoah SA (la Société)
|
— | — |
| Statement of IFRS compliance [text block] |
|
— | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories | — |
882,000
EUR
|
346,000
EUR
|
| Current trade receivables | — |
1 463
EUR
|
226,000
EUR
|
| Disclosure of objectives, policies and processes for managing capital [text block] |
|
— | — |